Fundraising FoxBioincept
Cherry Hill, US · Delaware LLC
Find your way into Bioincept
Sign up to see every warm intro you have to Bioincept
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Bioincept team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
JC
Julia CorelliBoard director
GW
George W. FrankBoard director
BO
Barton O'BrienBoard director
DS
Dennis SpinkBoard director
Reported raises · per SEC filings
Form D private placements$15.6M disclosed across 4 rounds · 2013–2020
▶$3.1MraisedOct 2020 · 28 investors · BiotechnologyRule 506(c)
▶$3.1MraisedOct 2020 · 28 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Brian FosterExecutive Officer
- David DuncanDirector
- George W Frank, Jr.Director
- Barton O'BrienDirector
- Dennis SpinkDirector
- Eytan R BarneaDirector
- Julia D CorelliDirector
- Offering amount
- $15M
- Amount sold
- $3.1M
- First sale
- Sep 2020
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06c
▶$2MraisedMar 2019 · 17 investors · BiotechnologyRule 506(b)
▶$2MraisedMar 2019 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dennis SpinkDirector
- Barton O'BrienDirector
- Jacqueline H BarneaDirector
- Julia D CorelliDirector
- Brian FosterExecutive Officer
- David R DuncanDirector
- George W Frank, Jr.Director
- Offering amount
- $8M
- Amount sold
- $2M
- First sale
- Feb 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$7.3MraisedDec 2016 · 38 investors · BiotechnologyRule 506(b)
▶$7.3MraisedDec 2016 · 38 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Julia CorelliDirector
- George W. FrankDirector
- Eytan R. BarneaExecutive Officer, Director
- Jacqueline H. BarneaExecutive Officer, Director
- Barton O'BrienDirector
- Dennis SpinkDirector
- Offering amount
- $7.3M
- Amount sold
- $7.3M
- Minimum investment
- $64.9K
- First sale
- Sep 2016
- Incorporated
- Limited Liability Company, New Jersey
- Federal exemptions
- 06b
▶$3.2MraisedApr 2014 · 39 investors · BiotechnologyRule 506(c)
▶$3.2MraisedApr 2014 · 39 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- George W. FrankDirector
- Eytan BarneaDirector
- Barton O'BrienDirector
- Jacqueline H. BarneaExecutive Officer, Director
- Dennis SpinkDirector
- Offering amount
- $6.5M
- Amount sold
- $3.2M
- First sale
- Aug 2013
- Incorporated
- Limited Liability Company, New Jersey
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Bioincept?
- Bioincept was founded by Eytan R. Barnea.
- How much funding has Bioincept raised?
- Bioincept has disclosed $15.6M raised across 4 rounds.
- Where is Bioincept headquartered?
- Bioincept is headquartered in Cherry Hill, US.